Clinical Performance Characteristics of the Adiana® System for Permanent Contraception: The First Year of Commercial Use

Reviews in Obstetrics and Gynecology

Seth J Herbst²  Edward G Evantash¹ 

[1] Department of Obstetrics and Gynecology, Tufts University School of Medicine, Associate Division Chief of General Obstetrics and Gynecology, Director of Center for Abnormal Uterine Bleeding, Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, MA;Institute for Women’s Health and Body, Wellington, FL

关键词: Adiana;    Hysteroscopic sterilization;    Female sterilization;   

DOI  :  

学科分类：医学（综合）

来源: MedReviews, LLC

【 摘 要 】

In 2009, the Adiana® System for Permanent Contraception was approved by the US Food and Drug Administration and became the second device on the market for hysteroscopic sterilization. This article outlines the basics of the Adiana procedure as it relates to the initial 12-month clinical experience following commercial launch. Safety, efficacy, and practical applications are explored to provide a better understanding of product performance characteristics in the first year of actual clinical use.

【 授权许可】

Unknown